Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pancreatic cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-8 of 8 for your search:
Start Over
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Combination Chemotherapy Followed by Ipilimumab and Vaccine Therapy in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9478, NCI-2013-02238, FD-R-004819-01, NA_00086350, J13108, NCT01896869
GVAX Pancreatic Cancer Vaccine, Pembrolizumab, and Stereotactic Body Radiation Therapy in Treating Patients with Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J15237, NCI-2016-00950, IRB00083132, CRMS-63195, NCT02648282
INO-1400 Vaccine Alone or in Combination with INO-9012 Followed by Electroporation in Treating Patients with Breast, Lung, or Pancreatic Cancer at High Risk of Relapse after Surgery and Standard Treatment
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #22913 / Inovio TRT-00, NCI-2015-00389, UPCC 22913, 821038, NCT02327468
Vaccine Therapy and Pembrolizumab in Treating Patients with Solid Tumors That Have Failed Prior Therapy
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15002, NCI-2015-00653, 122284, 122771, 116634, 124524, NCT02432963
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Vaccine Therapy with or without Nivolumab Before and After Surgery in Treating Patients with Stage I-IIb Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1568, NCI-2016-00268, IRB00050517, CRMS-61622, NCT02451982
Personalized Peptide Vaccine in Treating Patients with Advanced Pancreatic Cancer or Colorectal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-1029, NCI-2016-00015, NCT02600949
Start Over